Xin Du
- Hematology top 1%
- Acute Myeloid Leukemia Research 30
- Chronic Myeloid Leukemia Treatments 29
- Hematopoietic Stem Cell Transplantation 13
- Multiple Myeloma Research and Treatments 12
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 23
- Cancer Research top 5%
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 12
- Oncology top 5%
- CAR-T cell therapy research 10
-
- Atrial Fibrillation Management and Outcomes 10
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xin Du
195 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 152
- Hematology 906
- Genetics 520
- Cancer Research 430
- Molecular Biology 1.4k
- Oncology 518
Countries citing papers authored by Xin Du
This map shows the geographic impact of Xin Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Du more than expected).
Fields of papers citing papers by Xin Du
This network shows the impact of papers produced by Xin Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Du. The network helps show where Xin Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 16 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 10 | |
| 13 | 2023 | 10 | |
| 14 | 2022 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 32 | |
| 17 | 2018 | 26 | |
| 18 | 2017 | 27 | |
| 19 | 2016 | 53 | |
| 20 | 2010 | 261 |
About Xin Du
Xin Du is a scholar working on Hematology, Genetics and Oncology, having authored 227 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), Chronic Myeloid Leukemia Treatments (29 papers), Chronic Lymphocytic Leukemia Research (23 papers), Hematopoietic Stem Cell Transplantation (13 papers), Histone Deacetylase Inhibitors Research (12 papers), Multiple Myeloma Research and Treatments (12 papers), Atrial Fibrillation Management and Outcomes (10 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Hematology (906 citations), Genetics (520 citations) and Cancer Research (430 citations). Xin Du has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jingxuan Pan, Yanli Jin, Ke Ding, Preety Panwar, Dieter Brömme, Jianyu Weng, Zhongzheng Lu, Chun Chen, Yongbin Wu and Jing Zhou. Their work appears in journals such as Blood, Journal of Hematology & Oncology, Heart Rhythm, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.